Part 1
Part 2
Part 3
Part 5
Description
The global market for Non-Adhesive Liquid Embolic Agents was estimated to be worth US$ 133 million in 2023 and is forecast to a readjusted size of US$ 222 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030. Non-adhesive liquid embolic agents are a type of medical substance used in interventional procedures, particularly in endovascular embolization treatments, to block blood vessels. Unlike traditional adhesive embolic agents, which rely on chemical bonding to vessel walls, non-adhesive liquid embolics do not adhere to tissue but instead occlude blood flow by physically plugging the vessel lumen. These agents are typically delivered through a catheter and are designed to solidify or gel after being injected, forming a stable mass that prevents further blood flow. They are often used for treating conditions like arteriovenous malformations (AVMs), tumors, or aneurysms, where precise occlusion of abnormal blood vessels is required.
Non-Adhesive Liquid Embolic Agents Market Size
M= millions and B=billions
North American market for Non-Adhesive Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-Adhesive Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Non-Adhesive Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Non-Adhesive Liquid Embolic Agents include Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Non-Adhesive Liquid Embolic Agents, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-Adhesive Liquid Embolic Agents by region & country, by Type, and by Application.
The Non-Adhesive Liquid Embolic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Adhesive Liquid Embolic Agents.
Market Segmentation
Report Metric
Details
Report Title
Non-Adhesive Liquid Embolic Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 222 million
CAGR(2024-2030)
7.6%
Market Size Available for Years
2019-2030
Global Non-Adhesive Liquid Embolic Agents Companies Covered
Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech
Global Non-Adhesive Liquid Embolic Agents Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Non-Adhesive Liquid Embolic Agents Market, Segment by Type
EVOH-Based
Diluted Cyanoacrylate
Others
Global Non-Adhesive Liquid Embolic Agents Market, Segment by Application
Brain Arterio-Venous Malformations (bAVM)
Tumor Embolization
Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-Adhesive Liquid Embolic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Non-Adhesive Liquid Embolic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Non-Adhesive Liquid Embolic Agents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Non-Adhesive Liquid Embolic Agents Product Introduction
1.2 Global Non-Adhesive Liquid Embolic Agents Market Size Forecast
1.2.1 Global Non-Adhesive Liquid Embolic Agents Sales Value (2019-2030)
1.2.2 Global Non-Adhesive Liquid Embolic Agents Sales Volume (2019-2030)
1.2.3 Global Non-Adhesive Liquid Embolic Agents Sales Price (2019-2030)
1.3 Non-Adhesive Liquid Embolic Agents Market Trends & Drivers
1.3.1 Non-Adhesive Liquid Embolic Agents Industry Trends
1.3.2 Non-Adhesive Liquid Embolic Agents Market Drivers & Opportunity
1.3.3 Non-Adhesive Liquid Embolic Agents Market Challenges
1.3.4 Non-Adhesive Liquid Embolic Agents Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-Adhesive Liquid Embolic Agents Players Revenue Ranking (2023)
2.2 Global Non-Adhesive Liquid Embolic Agents Revenue by Company (2019-2024)
2.3 Global Non-Adhesive Liquid Embolic Agents Players Sales Volume Ranking (2023)
2.4 Global Non-Adhesive Liquid Embolic Agents Sales Volume by Company Players (2019-2024)
2.5 Global Non-Adhesive Liquid Embolic Agents Average Price by Company (2019-2024)
2.6 Key Manufacturers Non-Adhesive Liquid Embolic Agents Manufacturing Base and Headquarters
2.7 Key Manufacturers Non-Adhesive Liquid Embolic Agents Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-Adhesive Liquid Embolic Agents
2.9 Non-Adhesive Liquid Embolic Agents Market Competitive Analysis
2.9.1 Non-Adhesive Liquid Embolic Agents Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-Adhesive Liquid Embolic Agents Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Adhesive Liquid Embolic Agents as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 EVOH-Based
3.1.2 Diluted Cyanoacrylate
3.1.3 Others
3.2 Global Non-Adhesive Liquid Embolic Agents Sales Value by Type
3.2.1 Global Non-Adhesive Liquid Embolic Agents Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Non-Adhesive Liquid Embolic Agents Sales Value, by Type (2019-2030)
3.2.3 Global Non-Adhesive Liquid Embolic Agents Sales Value, by Type (%) (2019-2030)
3.3 Global Non-Adhesive Liquid Embolic Agents Sales Volume by Type
3.3.1 Global Non-Adhesive Liquid Embolic Agents Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Non-Adhesive Liquid Embolic Agents Sales Volume, by Type (2019-2030)
3.3.3 Global Non-Adhesive Liquid Embolic Agents Sales Volume, by Type (%) (2019-2030)
3.4 Global Non-Adhesive Liquid Embolic Agents Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Brain Arterio-Venous Malformations (bAVM)
4.1.2 Tumor Embolization
4.1.3 Others
4.2 Global Non-Adhesive Liquid Embolic Agents Sales Value by Application
4.2.1 Global Non-Adhesive Liquid Embolic Agents Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Non-Adhesive Liquid Embolic Agents Sales Value, by Application (2019-2030)
4.2.3 Global Non-Adhesive Liquid Embolic Agents Sales Value, by Application (%) (2019-2030)
4.3 Global Non-Adhesive Liquid Embolic Agents Sales Volume by Application
4.3.1 Global Non-Adhesive Liquid Embolic Agents Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Non-Adhesive Liquid Embolic Agents Sales Volume, by Application (2019-2030)
4.3.3 Global Non-Adhesive Liquid Embolic Agents Sales Volume, by Application (%) (2019-2030)
4.4 Global Non-Adhesive Liquid Embolic Agents Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Non-Adhesive Liquid Embolic Agents Sales Value by Region
5.1.1 Global Non-Adhesive Liquid Embolic Agents Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Non-Adhesive Liquid Embolic Agents Sales Value by Region (2019-2024)
5.1.3 Global Non-Adhesive Liquid Embolic Agents Sales Value by Region (2025-2030)
5.1.4 Global Non-Adhesive Liquid Embolic Agents Sales Value by Region (%), (2019-2030)
5.2 Global Non-Adhesive Liquid Embolic Agents Sales Volume by Region
5.2.1 Global Non-Adhesive Liquid Embolic Agents Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Non-Adhesive Liquid Embolic Agents Sales Volume by Region (2019-2024)
5.2.3 Global Non-Adhesive Liquid Embolic Agents Sales Volume by Region (2025-2030)
5.2.4 Global Non-Adhesive Liquid Embolic Agents Sales Volume by Region (%), (2019-2030)
5.3 Global Non-Adhesive Liquid Embolic Agents Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
5.4.2 North America Non-Adhesive Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
5.5.2 Europe Non-Adhesive Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
5.6.2 Asia Pacific Non-Adhesive Liquid Embolic Agents Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
5.7.2 South America Non-Adhesive Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
5.8.2 Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Value
6.2.1 Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
6.2.2 Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
6.3.2 United States Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Non-Adhesive Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
6.4.2 Europe Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Non-Adhesive Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
6.5.2 China Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
6.5.3 China Non-Adhesive Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
6.6.2 Japan Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Non-Adhesive Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
6.7.2 South Korea Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Non-Adhesive Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
6.8.2 Southeast Asia Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Non-Adhesive Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Non-Adhesive Liquid Embolic Agents Sales Value, 2019-2030
6.9.2 India Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
6.9.3 India Non-Adhesive Liquid Embolic Agents Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Company Information
7.1.2 Medtronic Introduction and Business Overview
7.1.3 Medtronic Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Medtronic Non-Adhesive Liquid Embolic Agents Product Offerings
7.1.5 Medtronic Recent Development
7.2 Balt Group
7.2.1 Balt Group Company Information
7.2.2 Balt Group Introduction and Business Overview
7.2.3 Balt Group Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Balt Group Non-Adhesive Liquid Embolic Agents Product Offerings
7.2.5 Balt Group Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Information
7.3.2 Johnson & Johnson Introduction and Business Overview
7.3.3 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Johnson & Johnson Non-Adhesive Liquid Embolic Agents Product Offerings
7.3.5 Johnson & Johnson Recent Development
7.4 Meril Life
7.4.1 Meril Life Company Information
7.4.2 Meril Life Introduction and Business Overview
7.4.3 Meril Life Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Meril Life Non-Adhesive Liquid Embolic Agents Product Offerings
7.4.5 Meril Life Recent Development
7.5 BlackSwan Vascular
7.5.1 BlackSwan Vascular Company Information
7.5.2 BlackSwan Vascular Introduction and Business Overview
7.5.3 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Product Offerings
7.5.5 BlackSwan Vascular Recent Development
7.6 Success Bio-Tech
7.6.1 Success Bio-Tech Company Information
7.6.2 Success Bio-Tech Introduction and Business Overview
7.6.3 Success Bio-Tech Non-Adhesive Liquid Embolic Agents Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Success Bio-Tech Non-Adhesive Liquid Embolic Agents Product Offerings
7.6.5 Success Bio-Tech Recent Development
8 Industry Chain Analysis
8.1 Non-Adhesive Liquid Embolic Agents Industrial Chain
8.2 Non-Adhesive Liquid Embolic Agents Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-Adhesive Liquid Embolic Agents Sales Model
8.5.2 Sales Channel
8.5.3 Non-Adhesive Liquid Embolic Agents Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Non-Adhesive Liquid Embolic Agents Market Trends
Table 2. Non-Adhesive Liquid Embolic Agents Market Drivers & Opportunity
Table 3. Non-Adhesive Liquid Embolic Agents Market Challenges
Table 4. Non-Adhesive Liquid Embolic Agents Market Restraints
Table 5. Global Non-Adhesive Liquid Embolic Agents Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Non-Adhesive Liquid Embolic Agents Revenue Market Share by Company (2019-2024)
Table 7. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Company (2019-2024) & (K Dose)
Table 8. Global Non-Adhesive Liquid Embolic Agents Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Non-Adhesive Liquid Embolic Agents Price by Company (2019-2024) & (US$/Dose)
Table 10. Key Manufacturers Non-Adhesive Liquid Embolic Agents Manufacturing Base and Headquarters
Table 11. Key Manufacturers Non-Adhesive Liquid Embolic Agents Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Non-Adhesive Liquid Embolic Agents
Table 13. Global Non-Adhesive Liquid Embolic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Adhesive Liquid Embolic Agents as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-Adhesive Liquid Embolic Agents Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Non-Adhesive Liquid Embolic Agents Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Non-Adhesive Liquid Embolic Agents Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Non-Adhesive Liquid Embolic Agents Sales Market Share in Value by Type (2019-2024)
Table 20. Global Non-Adhesive Liquid Embolic Agents Sales Market Share in Value by Type (2025-2030)
Table 21. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Type: 2019 VS 2023 VS 2030 (K Dose)
Table 22. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Type (2019-2024) & (K Dose)
Table 23. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Type (2025-2030) & (K Dose)
Table 24. Global Non-Adhesive Liquid Embolic Agents Sales Market Share in Volume by Type (2019-2024)
Table 25. Global Non-Adhesive Liquid Embolic Agents Sales Market Share in Volume by Type (2025-2030)
Table 26. Global Non-Adhesive Liquid Embolic Agents Price by Type (2019-2024) & (US$/Dose)
Table 27. Global Non-Adhesive Liquid Embolic Agents Price by Type (2025-2030) & (US$/Dose)
Table 28. Global Non-Adhesive Liquid Embolic Agents Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Non-Adhesive Liquid Embolic Agents Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Non-Adhesive Liquid Embolic Agents Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Non-Adhesive Liquid Embolic Agents Sales Market Share in Value by Application (2019-2024)
Table 32. Global Non-Adhesive Liquid Embolic Agents Sales Market Share in Value by Application (2025-2030)
Table 33. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Application: 2019 VS 2023 VS 2030 (K Dose)
Table 34. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Application (2019-2024) & (K Dose)
Table 35. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Application (2025-2030) & (K Dose)
Table 36. Global Non-Adhesive Liquid Embolic Agents Sales Market Share in Volume by Application (2019-2024)
Table 37. Global Non-Adhesive Liquid Embolic Agents Sales Market Share in Volume by Application (2025-2030)
Table 38. Global Non-Adhesive Liquid Embolic Agents Price by Application (2019-2024) & (US$/Dose)
Table 39. Global Non-Adhesive Liquid Embolic Agents Price by Application (2025-2030) & (US$/Dose)
Table 40. Global Non-Adhesive Liquid Embolic Agents Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
Table 41. Global Non-Adhesive Liquid Embolic Agents Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Non-Adhesive Liquid Embolic Agents Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Non-Adhesive Liquid Embolic Agents Sales Value by Region (2019-2024) & (%)
Table 44. Global Non-Adhesive Liquid Embolic Agents Sales Value by Region (2025-2030) & (%)
Table 45. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Region (K Dose): 2019 VS 2023 VS 2030
Table 46. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Region (2019-2024) & (K Dose)
Table 47. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Region (2025-2030) & (K Dose)
Table 48. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Region (2019-2024) & (%)
Table 49. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Region (2025-2030) & (%)
Table 50. Global Non-Adhesive Liquid Embolic Agents Average Price by Region (2019-2024) & (US$/Dose)
Table 51. Global Non-Adhesive Liquid Embolic Agents Average Price by Region (2025-2030) & (US$/Dose)
Table 52. Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Volume, (2019-2024) & (K Dose)
Table 56. Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Volume, (2025-2030) & (K Dose)
Table 57. Medtronic Company Information
Table 58. Medtronic Introduction and Business Overview
Table 59. Medtronic Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 60. Medtronic Non-Adhesive Liquid Embolic Agents Product Offerings
Table 61. Medtronic Recent Development
Table 62. Balt Group Company Information
Table 63. Balt Group Introduction and Business Overview
Table 64. Balt Group Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 65. Balt Group Non-Adhesive Liquid Embolic Agents Product Offerings
Table 66. Balt Group Recent Development
Table 67. Johnson & Johnson Company Information
Table 68. Johnson & Johnson Introduction and Business Overview
Table 69. Johnson & Johnson Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 70. Johnson & Johnson Non-Adhesive Liquid Embolic Agents Product Offerings
Table 71. Johnson & Johnson Recent Development
Table 72. Meril Life Company Information
Table 73. Meril Life Introduction and Business Overview
Table 74. Meril Life Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Meril Life Non-Adhesive Liquid Embolic Agents Product Offerings
Table 76. Meril Life Recent Development
Table 77. BlackSwan Vascular Company Information
Table 78. BlackSwan Vascular Introduction and Business Overview
Table 79. BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. BlackSwan Vascular Non-Adhesive Liquid Embolic Agents Product Offerings
Table 81. BlackSwan Vascular Recent Development
Table 82. Success Bio-Tech Company Information
Table 83. Success Bio-Tech Introduction and Business Overview
Table 84. Success Bio-Tech Non-Adhesive Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Success Bio-Tech Non-Adhesive Liquid Embolic Agents Product Offerings
Table 86. Success Bio-Tech Recent Development
Table 87. Key Raw Materials Lists
Table 88. Raw Materials Key Suppliers Lists
Table 89. Non-Adhesive Liquid Embolic Agents Downstream Customers
Table 90. Non-Adhesive Liquid Embolic Agents Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-Adhesive Liquid Embolic Agents Product Picture
Figure 2. Global Non-Adhesive Liquid Embolic Agents Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Non-Adhesive Liquid Embolic Agents Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Non-Adhesive Liquid Embolic Agents Sales Volume (2019-2030) & (K Dose)
Figure 5. Global Non-Adhesive Liquid Embolic Agents Sales Price (2019-2030) & (US$/Dose)
Figure 6. Non-Adhesive Liquid Embolic Agents Report Years Considered
Figure 7. Global Non-Adhesive Liquid Embolic Agents Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Non-Adhesive Liquid Embolic Agents Players Sales Volume Ranking (2023) & (US$ Million)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-Adhesive Liquid Embolic Agents Revenue in 2023
Figure 10. Non-Adhesive Liquid Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. EVOH-Based Picture
Figure 12. Diluted Cyanoacrylate Picture
Figure 13. Others Picture
Figure 14. Global Non-Adhesive Liquid Embolic Agents Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Non-Adhesive Liquid Embolic Agents Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Type (2019 VS 2023 VS 2030) & (K Dose)
Figure 17. Global Non-Adhesive Liquid Embolic Agents Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Non-Adhesive Liquid Embolic Agents Price by Type (2019-2030) & (US$/Dose)
Figure 19. Product Picture of Brain Arterio-Venous Malformations (bAVM)
Figure 20. Product Picture of Tumor Embolization
Figure 21. Product Picture of Others
Figure 22. Global Non-Adhesive Liquid Embolic Agents Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Non-Adhesive Liquid Embolic Agents Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Non-Adhesive Liquid Embolic Agents Sales Volume by Application (2019 VS 2023 VS 2030) & (K Dose)
Figure 25. Global Non-Adhesive Liquid Embolic Agents Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Non-Adhesive Liquid Embolic Agents Price by Application (2019-2030) & (US$/Dose)
Figure 27. North America Non-Adhesive Liquid Embolic Agents Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Non-Adhesive Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 30. Europe Non-Adhesive Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Non-Adhesive Liquid Embolic Agents Sales Value by Region (%), 2023 VS 2030
Figure 33. South America Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 34. South America Non-Adhesive Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Non-Adhesive Liquid Embolic Agents Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Non-Adhesive Liquid Embolic Agents Sales Volume (%), (2019-2030)
Figure 39. United States Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Non-Adhesive Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Non-Adhesive Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 45. China Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 47. China Non-Adhesive Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Non-Adhesive Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Non-Adhesive Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Non-Adhesive Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 57. India Non-Adhesive Liquid Embolic Agents Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Non-Adhesive Liquid Embolic Agents Sales Value by Type (%), 2023 VS 2030
Figure 59. India Non-Adhesive Liquid Embolic Agents Sales Value by Application (%), 2023 VS 2030
Figure 60. Non-Adhesive Liquid Embolic Agents Industrial Chain
Figure 61. Non-Adhesive Liquid Embolic Agents Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Description
The global market for Non-Adhesive Liquid Embolic Agents was estimated to be worth US$ 133 million in 2023 and is forecast to a readjusted size of US$ 222 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030. Non-adhesive liquid embolic agents are a type of medical substance used in interventional procedures, particularly in endovascular embolization treatments, to block blood vessels. Unlike traditional adhesive embolic agents, which rely on chemical bonding to vessel walls, non-adhesive liquid embolics do not adhere to tissue but instead occlude blood flow by physically plugging the vessel lumen. These agents are typically delivered through a catheter and are designed to solidify or gel after being injected, forming a stable mass that prevents further blood flow. They are often used for treating conditions like arteriovenous malformations (AVMs), tumors, or aneurysms, where precise occlusion of abnormal blood vessels is required.
North American market for Non-Adhesive Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-Adhesive Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Non-Adhesive Liquid Embolic Agents was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Non-Adhesive Liquid Embolic Agents include Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Non-Adhesive Liquid Embolic Agents, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-Adhesive Liquid Embolic Agents by region & country, by Type, and by Application.
The Non-Adhesive Liquid Embolic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Adhesive Liquid Embolic Agents.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-Adhesive Liquid Embolic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Non-Adhesive Liquid Embolic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Non-Adhesive Liquid Embolic Agents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now